ad

Morepen Laboratories Share Price Jumps to Fresh 52-Week High at Rs 127: Here’s Why

21 Sept 20269:54 am

Morepen Laboratories Share Price Jumps to Fresh 52-Week High at Rs 127: Here’s Why
Morepen Laboratories Ltd. (MOREPENLAB) share price reached a fresh 52-week high of Rs 126.9 today and later stood at Rs 125.45, up 3.76% from the previous close. Market cap was Rs 6,624.76 crore.

Morepen Laboratories Share Price is in focus after the stock rose to Rs 125.45 on 21 September 2026, up Rs 4.55 or 3.76%, and touched a fresh 52-week high of Rs 126.9. The company’s market capitalisation stands at Rs 6,624.76 crore. The move places Morepen Laboratories Ltd. (MOREPENLAB) in the day’s Stocks in News and 52 Week High Stocks list, but the supplied data confirms the price event and does not establish a company-specific catalyst. For readers tracking Morepen Laboratories Share Price Today, the key verified data point is simple: the stock printed a new yearly high while trading above its previous close of Rs 120.9.

At Univest, this event matters because it combines an intraday high with a measurable change in the share price, while also giving investors a current market capitalisation reference point. Morepen Laboratories Stock News therefore centres on the verified price action, the fresh one-year high, and the company’s basic valuation profile. Univest is using only supplied data here, so the article focuses on what happened, how the market cap frames the company, and what the numbers say about fundamental context.

Morepen Laboratories Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 125.45
Previous Close Rs 120.9
Today's Move +Rs 4.55 (+3.76%)
Open Rs 121.35
High Rs 126.9
Low Rs 120.9
Turnover Rs 7.59 crore
Market Capitalisation Rs 6,624.76 crore

Morepen Laboratories Ltd. (MOREPENLAB) traded at Rs 125.45 versus the previous close of Rs 120.9, a rise of 3.76%. The stock opened at Rs 121.35, reached a high of Rs 126.9 and touched a low of Rs 120.9.

Morepen Laboratories Share Price Today shows a clean upside session in which the stock opened at Rs 121.35, stayed above the previous close of Rs 120.9, and moved to a day low of Rs 120.9 before reaching Rs 126.9, which is also the fresh 52-week high. The close for the latest update is Rs 125.45, leaving the stock Rs 4.55 higher on the day.

The price range matters because it shows the day’s movement between the opening level, the low, and the high without needing any external explanation. The stock finished near the upper part of the day’s range, and the fresh yearly high keeps Morepen Laboratories Share Price in the spotlight for market participants following Morepen Laboratories Share Price Live updates. In percentage terms, the stock moved 3.76% higher versus the previous close. Since the previous 52-week high is not supplied, a breakout percentage cannot be calculated from the available data. Even so, Morepen Laboratories Share News is clearly defined by the new 52-week peak and the fact that the latest traded level remained above the earlier close. That is the main verified takeaway from today’s session and a useful bridge into the company’s financial backdrop.

Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis

Metric Value
Market Capitalisation Rs 6,624.76 crore
P/E Ratio 47.14x
P/B Ratio 5.09x
ROE 7.96%
ROCE 10.19%
EPS Rs 2.56
Book Value Per Share Rs 23.78
Dividend Yield 0.17%

Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 47.14x, P/B 5.09x, ROE 7.96%, ROCE 10.19%. These figures provide context only and are not a buy or sell signal.

Morepen Laboratories Ltd. has a market capitalisation of Rs 6624.76 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 47.14x, P/B at 5.09x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.96% and ROCE of 10.19%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.18x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 47.14x
Benchmark Median P/E 32.18x
Benchmark Average P/E 48.78x
Benchmark P/E Range 3.4x to 683.5x
Company P/B Ratio 5.09x
Benchmark Median P/B 3.04x
Company ROE 7.96%
Benchmark Median ROE 11.7%
Company ROCE 10.19%
Benchmark Median ROCE 13.61%
Company Market Capitalisation Rs 6,624.76 crore
Benchmark Median Market Cap Rs 677.56 crore

Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 47.14x, which is above the benchmark median of 32.18x, a difference of +46.49%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 7.96%, which is below the benchmark median of 11.7%, a difference of -31.97%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 10.19%, which is below the benchmark median of 13.61%, a difference of -25.13%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Innova Captab Ltd. INNOVACAP 6,756.83 43.23 5.95 13.75 15.04
SENORES PHARMACEUTICALS L SENORES 6,474.21 51.23 6.72 14.14 15.66
SYMBIOTEC PHARMALAB LTD SYMBIOTEC 7,024.8 63.92 4.73 11.22 12.41
Sanofi India Ltd. SANOFI 7,111.86 21.96 8.61 44.5 55.46
Bliss GVS Pharma Ltd. BLISSGVS 7,234.73 53.12 5.87 12.11 17.4

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 47.14x compared with the displayed peer median of 51.23x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.96% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 10.19% versus the displayed peer median of 15.66%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 6,624.76 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Morepen Laboratories

  • Morepen Laboratories Share Price hit a fresh 52-week high of Rs 126.9 and last quoted at Rs 125.45.
  • The stock ended the session Rs 4.55 higher, or 3.76% above the previous close of Rs 120.9.
  • Market capitalisation stands at Rs 6,624.76 crore, which places Morepen Laboratories Market Cap above the industry median in the benchmark set.
  • The P/E ratio of 47.14 is above the same-industry median of 32.18, while the P/B ratio of 5.09 is above the median of 3.04.
  • ROE of 7.96% and ROCE of 10.19% remain below the same-industry medians of 11.7% and 13.61%.

About Morepen Laboratories

Morepen Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not expand into business-segment detail, so the company profile here stays limited to the verified sector and industry classification. For readers following Morepen Laboratories Company News, this section is intentionally factual and narrow. Univest uses the same classification across Morepen Laboratories Stock Analysis, Morepen Laboratories Latest News and Morepen Laboratories Share Price Update content so the stock stays anchored to confirmed company data rather than inference.

Track Morepen Laboratories Share Price on Univest

Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Morepen Laboratories Share Price on Univest for live price updates, key fundamental ratios, shareholding pattern when available, market capitalisation, 52-week levels, and comparative market insights. Univest also helps users follow Morepen Laboratories Share Price Today alongside company-specific stock news and related sector context.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why did Morepen Laboratories Share Price hit a fresh 52-week high?

Ans. The supplied data confirms that Morepen Laboratories Share Price touched Rs 126.9, a fresh 52-week high. It does not establish a company-specific catalyst, so the event should be read as verified price action only.

What is Morepen Laboratories Share Price today?

Ans. Morepen Laboratories Share Price is Rs 125.45 in the latest update. The stock was Rs 4.55 higher, or 3.76% above the previous close of Rs 120.9, after reaching Rs 126.9 during the session.

What was the day’s high and low for Morepen Laboratories?

Ans. The day’s high was Rs 126.9 and the day’s low was Rs 120.9. The open was Rs 121.35, which places the close of Rs 125.45 near the upper part of the session range.

What is Morepen Laboratories market capitalisation?

Ans. Morepen Laboratories Market Cap stands at Rs 6,624.76 crore. That figure places the company above the same-industry market-cap median of Rs 677.56 crore in the supplied benchmark set. The company operates in the Healthcare sector.

How does Morepen Laboratories valuation compare with peers?

Ans. Morepen Laboratories Share Price is linked to a P/E of 47.14 and P/B of 5.09. In the peer set, those figures sit above some names like FDC Ltd., but below the much higher multiple seen in Orchid Pharma Ltd.

Is Morepen Laboratories trading above the industry median P/E?

Ans. Yes. Morepen Laboratories has a P/E ratio of 47.14, while the same-industry median is 32.18. The company is therefore trading above the benchmark median on this measure. The company trades at a P/E ratio of 47.14x.

What do Morepen Laboratories ROE and ROCE show?

Ans. Morepen Laboratories reports ROE of 7.96% and ROCE of 10.19%. Both are below the same-industry medians of 11.7% and 13.61%, which provides a clear profitability comparison. ROE stands at 7.96%.

What are the EPS, book value and dividend yield for Morepen Laboratories?

Ans. Morepen Laboratories reports EPS of Rs 2.56, book value of Rs 23.78 and dividend yield of 0.17%. These figures help frame earnings, accounting value and historical payout context for the stock.

Which sector and industry does Morepen Laboratories belong to?

Ans. Morepen Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification is central to Morepen Laboratories Fundamental Analysis and to the sector comparison used in this article.

Where can I track Morepen Laboratories Share Price live?

Ans. You can track Morepen Laboratories Share Price on Univest for live updates, valuation ratios, 52-week levels and company context. The same page also helps follow Morepen Laboratories Stock News and sector comparisons.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down